See the DrugPatentWatch profile for ozempic
When does Ozempic’s patent protection end?
Ozempic’s active ingredient is semaglutide. The date when Ozempic is “off patent” depends on which specific patent(s) you mean (drug substance, formulation, delivery device, and method-of-use patents can all have different expirations and can be extended with patent term adjustments).
DrugPatentWatch.com tracks semaglutide patent status and provides a way to see the specific “expires” dates it lists for Ozempic-related patents. You can check the current status there: https://www.drugpatentwatch.com/ (search “Ozempic” or “semaglutide”). [1]
Why “off patent” isn’t one single date
Even if the earliest foundational patent expires, brand manufacturers may still face later-expiring:
- additional patents on specific formulations or dosing regimens,
- patents tied to the pen/injector design,
- and regulatory exclusivities that can delay generic or biosimilar entry beyond the first patent expiry date.
So people often use “off patent” loosely, but the market outcome can hinge on the last blocking right, not just the first. [1]
Can generics or similar products launch immediately when the first patent expires?
Not necessarily. Generic drug entry depends on whether there are any remaining listed patents that block approval (for example, patents still in force), plus how regulators handle exclusivity and patent-by-patent legal challenges. For biologic-like products and complex IP estates, launch timing can be especially sensitive to which patents remain active. [1]
If you tell me which “Ozempic” you mean, I can narrow the date
To give a precise “off patent” timeframe, it helps to know whether you mean:
- the original Ozempic brand (US vs. EU vs. UK),
- a specific strength (e.g., 0.5 mg vs 1 mg),
- and whether you mean “first patent expires” or “last patent expires.”
If you share the country (US/EU/UK) you care about, I can point to the corresponding Ozempic semaglutide patent expirations from DrugPatentWatch. [1]
Sources:
[1] https://www.drugpatentwatch.com/